Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status. 2004

Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
Diabetes Service, Department of Medicine, University of Sassari, Sassari, Italy. patbri@katamail.com

Oxidized low-density lipoproteins (ox-LDLs) and their autoantibodies (OLAB) are involved in the development of atherosclerosis in animal models, but their role in humans is still not clear. For this reason we studied 54 patients with beta-thalassemia major (TM), as a model of chronically low circulating LDLs with a high level of oxidation; 44 patients with primary hypercholesterolemia, as model of chronically high circulating LDLs; 24 type 2 diabetic mellitus patients (T2DM) before and after 3 months of atorvastatin treatment (20 mg/day), as a model of acute changes in circulating LDLs; and 41 normolipidemic subjects as a control group. ox-LDLs were measured by the determination of baseline diene concentration in the plasma LDL lipidic fraction after 12 hours fasting and were expressed as the amount of conjugated dienes/ liter (BDC/I) or BDC/LDL-cholesterol (LDL-C), which indicate respectively LDL oxidation degree and status. OLAB were determined using an enzyme immunoassay and related to LDL oxidation degree (BDC/I). In TM, BDC/I was lower, while BDC/LDL-C was significantly higher, compared to both hypercholesterolemia and normolipidemic subjects. Patients with hypercholesterolemia had higher BDC/I, but lower BDC/LDL-C and OLAB/BDC-I, than normolipidemic subjects. In T2DM patients at diet, BDC/LDL-C and OLAB/BDC-I were lower than in normolipidemic subjects. After 3 months of atorvastatin treatment, BDC/ LDL-C and OLAB/BDC-I ratios increased. When all patients were evaluated together, a significant inverse correlation was evident between OLAB and either LDL or BDC/I. Our findings suggest that a relationship between OLAB titer and oxidation indices (BDC/I and BDC/LDL-C) does exist and we may speculate that an increase in OLAB/BDC-I ratio might be protective against the risk of atherosclerosis.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
September 2016, Clinical laboratory,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
November 2023, Advanced healthcare materials,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
January 2005, Clinical and experimental rheumatology,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
September 1997, British journal of rheumatology,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
October 2009, Journal of biomechanics,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
December 2007, Journal of agricultural and food chemistry,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
May 1999, Annals of clinical biochemistry,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
December 2021, Bioengineered,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
May 1997, Clinical and experimental immunology,
Patrizia Brizzi, and Giancarlo Tonolo, and Graziano Bertrand, and Francesca Carusillo, and Cristiana Severino, and Mario Maioli, and Lucia Malaguarnera, and Salvatore Musumeci
July 2002, Clinical nephrology,
Copied contents to your clipboard!